Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 8/20 | 0.59 |
| ▸ | CYP1A1 | P04798 | 4/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.56 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.56 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.56 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.49 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2119793 | 0.93 | NFE2L2 (0.63) | NFE2L2CYP1A1CYP1A2CYP1B1PRMT1 | |
| SCHEMBL8494360 | 0.93 | NFE2L2 (0.63) | NFE2L2CYP1A1CYP1A2CYP1B1PRMT1 | |
| SCHEMBL21798669 | 0.91 | NFE2L2 (0.66) | NFE2L2CYP1A1CYP1A2CYP1B1PRMT1 | |
| SCHEMBL118591 | 0.82 | NFE2L2 (0.79) | NFE2L2CYP1A1CYP1A2CYP1B1PRMT1 | |
| SCHEMBL615385 | 0.80 | NFE2L2 (0.77) | NFE2L2CYP1A1CYP1A2CYP1B1PRMT1 | |
| SCHEMBL29915796 | 0.80 | NFE2L2 (0.49) | NFE2L2CYP1A1CYP1A2CYP1B1PRMT1 | |
| SCHEMBL28495425 | 0.80 | NFE2L2 (0.49) | NFE2L2CYP1A1CYP1A2CYP1B1PRMT1 | |
| SCHEMBL28495426 | 0.80 | NFE2L2 (0.49) | NFE2L2CYP1A1CYP1A2CYP1B1PRMT1 | |
| SCHEMBL27702145 | 0.79 | NFE2L2 (0.60) | NFE2L2CYP1A1CYP1A2CYP1B1PRMT1 | |
| O-Veratraldehyde SCHEMBL29923149 | 0.78 | SRC (0.67) | NFE2L2CYP1A1CYP1A2CYP1B1PRMT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090304620-A1 | HAIR TREATMENT PRODUCTS COMPRISING POLYMERS | HENKEL AG & CO. KGAA (DE) | 2009-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090304620-A1 | HAIR TREATMENT PRODUCTS COMPRISING POLYMERS | ASS1, SRM, COL1A1 | NFE2L2 3301/4885CYP1A1 190/4885CYP1A2 242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.